Smith Salley Wealth Management Sells 2,981 Shares of Chemed Corporation $CHE

Smith Salley Wealth Management lessened its holdings in shares of Chemed Corporation (NYSE:CHE) by 17.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,570 shares of the company’s stock after selling 2,981 shares during the period. Smith Salley Wealth Management’s holdings in Chemed were worth $6,524,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Dynamic Technology Lab Private Ltd bought a new stake in shares of Chemed during the 1st quarter valued at $891,000. Vontobel Holding Ltd. raised its position in shares of Chemed by 44.5% in the 2nd quarter. Vontobel Holding Ltd. now owns 2,821 shares of the company’s stock valued at $1,374,000 after buying an additional 869 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new position in shares of Chemed in the 2nd quarter valued at approximately $342,000. Signal Advisors Wealth LLC lifted its holdings in shares of Chemed by 49.5% during the 2nd quarter. Signal Advisors Wealth LLC now owns 9,586 shares of the company’s stock worth $4,667,000 after acquiring an additional 3,174 shares during the period. Finally, Covea Finance boosted its position in shares of Chemed by 52.3% during the 2nd quarter. Covea Finance now owns 9,900 shares of the company’s stock worth $4,821,000 after acquiring an additional 3,400 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the transaction, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at approximately $41,215,897.35. This trade represents a 2.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.29% of the company’s stock.

Chemed Stock Down 0.8%

Shares of NYSE CHE opened at $430.83 on Wednesday. The company has a market capitalization of $6.10 billion, a PE ratio of 22.78, a P/E/G ratio of 2.43 and a beta of 0.46. Chemed Corporation has a twelve month low of $408.42 and a twelve month high of $623.60. The firm has a fifty day simple moving average of $435.11 and a 200 day simple moving average of $452.34.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, October 28th. The company reported $5.27 EPS for the quarter, missing the consensus estimate of $5.39 by ($0.12). The business had revenue of $624.90 million for the quarter, compared to the consensus estimate of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $5.64 EPS. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, equities analysts expect that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Monday, November 17th were issued a $0.60 dividend. The ex-dividend date was Monday, November 17th. This represents a $2.40 annualized dividend and a yield of 0.6%. Chemed’s dividend payout ratio is presently 12.69%.

Analysts Set New Price Targets

CHE has been the subject of a number of research reports. Royal Bank Of Canada dropped their target price on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a report on Monday, November 10th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, October 8th. Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and increased their price target for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Finally, Bank of America lowered their price objective on Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $574.25.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.